World Asthma Day is an annual event organized by the Global Initiative for Asthma (GINA). The event raises awareness about asthma and works to improve asthma care around the world. This year’s theme is “You Can Control Your Asthma”. It aims to continue the focus on asthma control described in the latest version of the GINA guidelines .
The United States has one of the safest food supplies in the world. Nevertheless, according to the Centers for Disease Control and Prevention (CDC), foodborne disease causes approximately 76 million illnesses, 325,000 hospitalizations and 5,000 deaths in the U.S. each year  — and that’s just an estimate based on data collected from the Foodborne Diseases Active Surveillance Network (FoodNet), other surveillance networks and published studies.
The single largest cause of adult disability in the developed world is ischemic stroke, in which blood flow in or to the brain is blocked. It precipitates immense amounts of social and financial costs. Currently, therapies for stroke focus on prevention or acute phase treatments that arrest the stroke while it is happening. But many patients are not fortunate enough to get acute phase treatment and suffer neurological damage that leads to functional and cognitive impairment. Until now, there have been almost no options for such patients. But last February, a company called ReNeuron received approval to begin a clinical trial of neural stem cell therapy for disabled stroke patients . Two patients have been treated thus far and the therapy appears to be safe.
In President Barack Obama’s State of the Union address last month, he argued that government support for research and development to fund innovation is a necessary and critical investment that must be made, even in the face of a rising national debt. A coalition of biomedical researchers support his vision on science. The 2012 budget President Obama sent to Congress earlier this month seeks an increase in funding for biomedical research at the National Institutes of Health (NIH) and in basic science at other agencies, while making cuts and freezes in many other areas of government.
Earlier this month, Indiana University announced a major commitment to research in one of healthcare’s most promising fields, personalized medicine. The Indiana Institute for Personalized Medicine will pursue genome-based and pharmacogenomics studies in cardiology, pediatrics, obstetrics and cancer, as well as other areas . The emergence of personalized medicine, which targets individualized treatment and care based on personal and genetic variation, is creating a thriving market. Indeed, the market for personalized medicine in the United States is $232 billion and is projected to grow 11% annually .